Osteonecrosis of the Jaw Associated With Bevacizumab in Treatment: A Case Series Using the FDA Adverse Event Reporting System (FAERS) Database

被引：0
|
作者：
Ahdi, Hardeep S. [1 ]
Wichelmann, Thomas A. [2 ]
Pandravada, Sasirekha [2 ]
Ehrenpreis, Eli [3 ]
机构：
[1] Advocate Lutheran Gen Hosp, Chicago, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[3] Advocate Lutheran Gen, Evanston, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S166
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [41] Adverse event signal analysis of remimazolam using the FDA adverse event reporting system database
    Liu, Hongtao
    Li, Zhaoyu
    Yan, Su
    Ming, Shaopeng
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2025, 69 (03)
  • [42] Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
    Sato, Kenichiro
    Mano, Tatsuo
    Iwata, Atsushi
    Toda, Tatsushi
    BIOSCIENCE TRENDS, 2020, 14 (02) : 139 - 143
  • [43] Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
    Tian, Xiaojiang
    Chen, Lin
    Chen, Yonghong
    Zhang, Ni
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [44] Adverse events associated with acute pancreatitis caused by immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
    Tong, Lihua
    Yuan, Yanling
    He, Wanming
    Yang, Wen
    Pan, Xingxi
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [45] Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database
    Yin, Yi
    Jiang, Jie
    Jin, Youpeng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [46] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [47] Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database
    Shu, Yamin
    Ding, Yufeng
    He, Xucheng
    Liu, Yanxin
    Wu, Pan
    Zhang, Qilin
    CANCER MEDICINE, 2023, 12 (03): : 3365 - 3375
  • [48] SAFETY EVALUATION OF ZOLEDRONIC ACID AND DENOSUMAB USING FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE 2012-2018
    Elsisi, Z.
    Lin, A. C.
    Guo, J.
    VALUE IN HEALTH, 2019, 22 : S169 - S169
  • [49] Safety profile analysis of Sunitinib and Dasatinib protein kinase inhibitors using FDA adverse event reporting system (FAERS) database
    Alyami, Fatimah
    Guo, Jeff J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 335 - 336
  • [50] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
12345